Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
906
-
Total 13F shares, excl. options
-
92.2M
-
Shares change
-
-2.03M
-
Total reported value, excl. options
-
$49.5B
-
Value change
-
-$1.11B
-
Put/Call ratio
-
1.21
-
Number of buys
-
465
-
Number of sells
-
-319
-
Price
-
$536.95
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q4 2021
1,016 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q4 2021.
DEXCOM INC - Common Stock (DXCM) has 906 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.2M shares
of 392M outstanding shares and own 23.5% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.4M shares), BlackRock Inc. (8.13M shares), FMR LLC (4.54M shares), BAILLIE GIFFORD & CO (4.51M shares), STATE STREET CORP (4.05M shares), SANDS CAPITAL MANAGEMENT, LLC (3.13M shares), JPMORGAN CHASE & CO (2.93M shares), Capital Research Global Investors (2.37M shares), Nuveen Asset Management, LLC (2.05M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.87M shares).
This table shows the top 906 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.